Health Bulletin 7/January/2022

Here are the top health stories for the day:

CDSCO issues medical device alert for Abbott MitraClip Device

Suspecting the risk of potential clip lock malfunctions with MitraClip Clip Delivery Systems manufactured by Abbott, the Central Drugs Standard Control Organization (CDSCO) has issued a Medical Device Alert for MitraClip G4 Clip Delivery System and MitraClip NTR/XTR Clip Delivery System which are used as heart valve repair device, intended to treat mitral regurgitation.

This medical device alert follows the release of a medical device safety notice by Abbott subsidiary St. Jude Medical India, which said that the company had noticed an increase in complaints concerning clip locking issues with the MitraClipTM Delivery System.

For more details, check out the link given below:

CDSCO Issues Medical Device Alert For Abbott MitraClip Device

Two heart attacks after spinal decompression: NCDRC exonerates neurosurgeon, anesthetist of Fortis Hospital from negligence after 15 years

The National Consumer Disputes Redressal Commission (NCDRC) recently exonerated Fortis Hospital and its doctors from charges of medical negligence while conducting Spinal decompression on a patient back in 2005.

It was opined by the Apex consumer court that there was no deficiency in service after the Commission took note of the fact that even though the treating surgeon was absent after the operation, the patient was constantly under observation of other doctors, who managed the sudden post-operative cardiac complications of the patient and shifted the patient to other hospital.

Two Heart Attacks After Spinal Decompression: NCDRC Exonerates Neurosurgeon, Anesthetist Of Fortis Hospital From Negligence After 15 Years

Uzbekistan arrests four over Indian cough syrup deaths

Uzbekistan has arrested four people in an investigation into the deaths of 19 children who consumed cough syrup made by Indian drug maker Marion Biotech, the Uzbek state security service said on Friday.

Two of the detained were senior employees of the Scientific Center for Standardization of Medicines, who circumvented the proper testing procedures for the Doc-1 Max cough syrup, it said.

Two others were executives of the Quramax Medikal company that imported the Marion Biotech drugs. Marion Biotech said last month, shortly after the series of deaths, that it had halted production of the syrup.

For more details, check out the link given below:

Uzbekistan: Four Held Over Indian Cough Syrup Deaths